AU632481B2 - Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration - Google Patents

Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration Download PDF

Info

Publication number
AU632481B2
AU632481B2 AU34260/89A AU3426089A AU632481B2 AU 632481 B2 AU632481 B2 AU 632481B2 AU 34260/89 A AU34260/89 A AU 34260/89A AU 3426089 A AU3426089 A AU 3426089A AU 632481 B2 AU632481 B2 AU 632481B2
Authority
AU
Australia
Prior art keywords
treatment
injectable
per day
magnetized
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU34260/89A
Other versions
AU3426089A (en
Inventor
Walter Whitson Fischman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU3426089A publication Critical patent/AU3426089A/en
Application granted granted Critical
Publication of AU632481B2 publication Critical patent/AU632481B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Description

OP I PCTa wo' AOJP w
PCT
EB
I :il( DATE 16/10/89 DATE, 09/11/89 APPLN. ID 34260 89 PCT NUMBERPCT/US89/01400 INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCY) r
L
(51) International Patent Classification 4: A61K 9/14, B01J 13/02 (21) International Application Number: PCT/US89/01400 GA (OAPI patent), GB (European patent), HU, IT (European patent), JP, LK, LU (European patent), (22) International Filing Date: 3 April 1989 (03.04.89) ML (OAPI patent), MR (OAPI patent), NL (European patent), NO, IE (European patent), SN (OAPI patent), SU, TD (OAPI patent), TG (OAPI patent).
(31) Priority Application Number: 176,731 (32) Priority Date: 1 April 1988 (01.04.88) Published With international search report.
(33) Priority Country: US (71)(72) Applicant and Inventor: FISCIMAN, Walter, Whitson [US/US]; 325 East 65th Street, New York, NY 10021 (US).
(74) Agent: HAUG, Edgar, Curtis, Morris Safford, 530 Fifth Avenue, New York, NY 10036 (US).
(81) Designated States: AT (European patent), AU, BE (European patent), BF (OAPI patent), BJ (CAPI patent), BR, CF (OAPI patent), CG (OAPI patent), CH (European patent), CM (OAPI patent), DE (European patent), DK, FI, FR (European patent), (54)Title: MAGNETICALLY INFLUENCED HOMEOPATHIC PHARMACEUTICAL FORMULATIONS, METH- ODS OF THE'R PREPARATION AND METHODS OF THEIR ADMINISTRATION (57) Abstract A method for treating pathogenic conditions of the human body by preparing a mixture of at least one herb, herbal extract or other compound exhibiting therapeutic properties, adding a magnetically permeable substance to the mixture, magnetizing the resulting mixture to impart a substantially unipolar manetic ,harge on the mixture and administering the magnetized mixture through one or more specific acupuncture points associated with producing a desired response to the particular condition being treated. The invention is also directed to the treatment cf various diseases through the oral, aurici'tir, topical or injectable administration of homeopathic medicaments.
KZ
q PCT/US89/01 4 00 WO 89/09049 -12y WO 89/09049 PCT/US89/01400 -1- MAGNETICALLY INFLUENCED HOMEOPATHIC PHARMACEUTICAL FORMULATIONS METHODS OF THEIR PREPARATION AND METHODS OF THEIR ADMINISTRATION.
FIELD OF THE INVENTION This invention relates to homeopathic medicaments and methods for the treatment of illness and injury in human beings uEira such homeopathic medicaments.
More particularly, the invention relates to homeopathic methods of treatment of conditions including illnesses, pathogenic diseases, allergies, chemical and hormonal imbalances, addictive chemical dependencies, and physical injuries to the human body. The methods of treatment include oral, topical, auricular and injectable forms of homeopathic formulations which are magnetically treated or influenced during administeration to a patient through specific acupuncture points.
BACKGROUND OF THE INVENTION Homeopathy is an ancient healing art and forms a vital part of medical therapy. The practice of homeopathy is widespread, particularly in eastern cultures and many European countries. Homeopathic medicine teaches the use of natural based remedies and, as such, provides an.alternative to traditional allopathic medicine which relies heavily on the use of petrochemical based pharmaceuticals. There has been a large increase in interest in homeopathic medicine in the United-States in recent years due, in large part, to a growing disenchantment with allopathic medications and the complications and side effects arising from their use.
Frequently, the administration of allopathic medications results in serious side effects more deleterious to the patient than the basic condition being treated. Today, more and more individuals are looking for a gentler, safer path to good health free of the risks and side effects associated with traditional allopathic medicine. Furthermore, such medicines are often prohibitively expensive, particularly for patients who are indigent or elderly.
Homeopathic remedies, on the other hand, use pharmaceutical preparations based on the use of herb's6or herbal extracts. Homeopathic remedies function in a \ttallv different manner than chemical-based pharmaceuticals i )that i h i i- LIJ pCT/US9/O400 WO 891949 -13i;_i.il- 'i WO 89/0)9049 PCT/US89/01400 they do not require administering high concentrations of active ingredient to produce the desired results. Traditional allopathic pharmaceuticals can be thought of as working quantitatively, that is, the results achieved are generally proportional to the potency and frequency of the dosage administered. By comparison, homeopathic pharmaceuticals can be thought of as working qualitatively in that even the minutest quantities of their active ingredients produce a therapeutic effect by inducing natural body mechanisms to return to their proper level of activity characteristic of a healthful or uninjured state. Homeopathic remedies function by inducing natural body mechanisms and processes to return to their optimum healthful level of operation; that is, their natural biological "set points".
Through our modern understanding of genetics each bodily member and process is seen as the result of codes programed into each individual cell. Homeopathic medicine seeks to utilize natural substances, particularly herbs, to naturally and gently induce the body to restore its equilibrium, that is, for all function and processes to return to their set points. Homeopathic medicine looks upon illness and disease as being a state of disequilibrium from the body's optional set points. A fundamental precept of homeopathic medicine is that a small force or stimulating agent can produce disproportionally greater results, if optimally and effectively applied. Thus, proper administration of a small quantity of a homeopathic medicine can have a large effect in restoring the body to its proper state of equilibrium.
A further advantage of homeopathic medicaments is that they are relatively inexpensive as compared to traditional chemical-based pharmaceuticals. Another fundamental precept in the formulation of homeopathic pharmaceuticals is that repetitive dilution from an original concentrate does not diminish efficacy of the formulation.
Thus, large quantities of homeo athic,.pha*maceuticals can be prepared from a relatively small \amunt of Starting solution.
K
F-"
i -i I i i 1 1"11--; PCT/US89/0j4 0 WO 89/09049 -3- Further, the starting ingredients themselves are natural and relatively inexpensive. The formulation of sol tions of homeopathic pharmaceuticals is also a relatively simple process.
In contrast, the manufacture of traditional chemical-based pharmaceuticals generally involves a complicated and costly chemical manufacturing process. Moreover, because the effectiveness of such traditional chemical-based pharmaceuticals resides in the potency of the formulation administered, dilution of the pharmaceutical to a lower potency results in reduced effectiveness. Generally, all such chemical-based pharmaceuticals must be formulated at or near the concentration level or potency at which they will ultimately be administered. Thus, in order to produce large auantities of a pharmaceutical, proportionately large manufacturing facilities are reuuired, which only further adds to the expensiveness of the chemical-based pharmaceuticals utilized in classical allopathic medicine.
Another ancient and long accepted healing art is acupuncture which is believed to have originated in the Orient. Acupuncture involves the relief of symptoms and the cure of illness and injury by the controlled stimulation of points on the human body which regulate or interact with the functioning of specific organs or bodily members to which the acupuncture points are related.
Modern science has tried to determine the mechanism by which acupuncture works. One proposed explanation is that stimulation of acupuncture points on the body causes the release of endorphirs by the body. Endorphins are natural substances ':eeased within the body which, among other functions, operate to desensitize neurological pathways by which pain is perceived. By relieving the pain associated with symptoms and with illness and injury, the body itself is then able to utilize its naturao' immune system and the healing process to restore equilibrium and a normal healthful condition. Natural set points are restored and the affliction thereby eliminated. Pain acts as a warning indicator that i f i: e :s, wo f
IV
1 PCT/US89/01400 19/09049 -4-
**V
something is wrong in the body. By determining the source of the pain and the acupuncture points on the body to which the pain is responsive, the pain cycle can be broken and the natural healing process induced. Stimulation through acupuncture, which typically involves the insertion of small needles into the acupuncture points on the body, causes a release of endorphins which block pain sensed over the neurological pathways and enable other natural healing mechanisms in the body to restore a condition of homeopathic equilibrium to the body by killing invasive pathogens, restoring chemical or hormonal imbalance, or fostering the mending of physically injured tissues, muscles and/or bones. Over the many years that acupuncture has been practiced, specific points on the human body have been determined which regulate the functioning of all bodily members and processes. Thus, the appropriate points for stimulation for any given condition are known to skilled practitioners in the art.
One particular acupuncture treatment system developed in Japan by Dr. Yoshio Manaka is based on a conception of the human body as encompassiny two basic systems, an energetic system and an informational system. The energetic system utilizes the greater portion of energy in the body. The informational system controls the energetic system and responds to both external and internal stimuli.
Acupuncture is viewed as a therapeutic modality which interacts with and regulates the body's informational system.
By influencing the informational system, large changes can be induced with minimal stimulation while allowing the body to function as naturally as possible while its processes are gradually restored to their equilibrium set points.
A recent development in methods of medical treatment has been the discovery of the therapeutic properties of magnetic and electro-magnetic fields and their use in the treatment of illness and injury. Modern science has demonstrated that all living beings exhibit an electromagnetic field about them. Homeopathic medicine teaches that illness and injury create disturbances to the body's natural 1 1 o jil 1i PCTJUS89/01400 Wo 89/09049 I WO 89/09049 PCT/US89/01400 electro-magnetic fields. The administration of therapeutic fields restores the body's natural fields to their equilibrium levels. The therapeutic effects of the application of pulsed magnetic fields in the treatment of traumatic injuries to limbs, muscles, tendons, bones and the like, as well as in the treatment of illness such as arthritis, is well-known in the art of medical science.
The human body's susceptibility to magnetic fields is due in large part to the electrolytic properties of many of the chemical constituents of the body. All electrolytic substances are capable of conducting an electric current and wherever an electric current is flowing, a magnetic field is created. The greater the electrolytic properties of the substance, the greater is its conductivity and therefore the greater the resulting magnetic field created during current flow.
The body generates a magnetic field of its own due partly to the presence of iron-carrying charged particles flowing in the blood stream. Other electrolytic substances in the body such as potassium and sodium, in ionic form, are present in substantial amounts and contribute to the body's overall bioelectric/biomagnetic field. It is well known that blood cells are readily polarized when placed in a magnetic field due to the high iron concentration in the blood. Under certain conditions, magnetic fields alter the orientation of blood cells and induce changes in the biological reactions in which they participate, thereby modifying the probability of chemical bond formation.
Human blood is very slightly alkaline with respect to body cells which are more acidic. Magnetic fields can be used to induce reactions which restore the pH of the blood.
For example, in a condition prompted by over-acidity of the blood, that is, one characterized by a low pH, application of magnetic field energy, emanating from the north pole of a magnet, which, by coniventon, is considered to be negative, and which, homeopathically, is considered to be alkaline, i helps to restore the blood to its normal pH level.
iI -6 It has also been shown that the blood's leucocyte count is influenced by magnetic fields. The number of leucocytes in the blood increases or decreases depending on prevailing magnetic field conditions.
Therapeutic treatments utilizing magnetic energy operate to produce two curative effects. Therapeutic magnetic fields produce a treatment component which in the case of traumatic physical injury causes a reduction in swelling, a reduction of edema, a draining of fluid build-up due to inflammation and a desensitization to pain.
Therapeutic magnetic energy fields also produce a stimulating component which in the case of traumatic physical injury dilates blood vessels and increases blood circulation, disperses fluid build-up due to inflammation, and strengthens and promotes the healing of damaged tissue.
:i The application of pulsed magnetic energy has been S* 'observed to cause transcutaneous electrical neural 20 stimulation and contributes to the reduction of chronic pain by causing the release of natural pain relieving substances at the spinal cord level and by causing the release of endorphins and ACTH at the pituitary gland level.
25 As a result of research into the fields of homeopathic pharmaceutical medicine, acupuncture and biomagnetic therapy, a new modality of medical treatment has been developed which combines the features of all three of the above treatment methods in a novel way.
Accordingly, a new and unique method of medical teatment has been discovered which is more efficacious than any of the three methods described above.
EMBODIMENTS OF THE INVENTION Accordingly, one embodiment of the present invention can provide a modality of medical therapy which utilizes aspects of homeopathic pharmaceutical therapy, acupuncture therapy and biomagnetic therapy, in combination.
4 S 21535A 7 Another embodiment of the invention may provide a full range of modes of administration of magnetically induced homeopathic remedies, including topical, injectable, auricular and oral forms.
A further embodiment of the invention can provide particular homeopathic pharmaceutical formulations for the treatment of specific illnesses, physical injuries and other chemical and hormonal disequilibrium conditions of the human body with precisely determined acupuncture sites to which the homeopathic pharmaceutical remedies are to be applied in the treatment of each specific condition.
Yet a further embodiment of the invention may provide appropriate means for inducing the biomagnetic field in the homeopathic pharmaceutical remedy for each form of administration.
.tiMMARY OF THE INVENTION The present invention is directed to a method of treatment of human illness and injury by administering to the patient homeopathic medicaments through selected acupuncture points stimulated by a controlled magnetic field. A very broad spectrum of human illnesses can be effectively treated by homeopathic medicaments of the instant invention through selection of the appropriate homeopathic remedy, preparation of a mixture of the homeopathic remedy and a magnetically permeable component *and magnetization of the resulting mixture during administration to the patient through specific acupuncture sites.
Thus the present invention provides a method for treating pathogenic conditions of the human body comprising the steps of: preparing a therapeutically effective amount of a mixture of at least one herb, herbal extract or other compound having therapeutic properties to which a particular condition being treated is responsive; adding a magnetically permeable active substance to the mixture; i We l t-19yr-- -M ~I.V! 7Ag.,
S.
magnetizing the resulting mixture in a magnetic field to impart a 3ubstantially unipolar magnetic charge on said mixture; and administering the magnetized mixture through one or more specific acupuncture points of the body which are associated with producing a desired response to the particular condition being treated.
By the term "magnetically permeable substance" as used throughout the specification it is meant a substance that will accept and hold a magnetic charge; ie. that is magnetizable.
In a second aspect the present invention provides a method for the treatment of at least one of gastric discomfort, borborygmi and flatus in human beings comprising the administration of an oral form of a therapeutic amount of a magnetized solution containing as a solute the herb Coryandius sativa or an extract thereof and as a solvent a mixture of 99+% alcohol, diluted with ethanol, together with a magnetically permeable, nontoxic substance; wherein the oral form is a milk-sugar tablet carrier impregnated with the oral form solution; the tablet having a homeopathic potency of 5X; wherein the tablet is allowed to dissolve in the mouth to coat the acupuncture points in the mucous membrane of the mouth with the solution.
Also well known to those skilled in the art is the expression "homeopathic potency". Homeopathic potency relates to the degree of dilution and is standard terminology in traditional homeopathy. A traditional 30 homeopathic procedure involves a one to ten dilution.
Each time the one to ten dilution is repeated, the resulting potency changes by one increment. The scale for such change is noted by the symbol Thus, the first one to ten dilution is named the fifth dilution is named the thirtieth dilution is named and so on.
In a third aspect the present invention provides a Smethod for the treatment of nicotine addiction and the S:21535A Kgs pp WO 89/09049 PCT/US89/01400 7B craving to smoke cigarettes, other nicotine containing tobacco products, and the like in human beings, comprising the administration of an injectable form of a therapeutic amount of a magnetized solution containing as a solute cigarette smoke or an extract thereof and as a solvent a mixture of 99+% alcohol diluted with sterile isotonic saline, together with a magnetically permeable, non-toxic substance; the injectable solution having a homeopathic potency of 30X, wherein the solution is injected in an amount of 0.2 cc per acupuncture point, bilaterally at two special acupuncture points of the body.
When the term "unipolar magnetic charge" is used throughout the specification it is a reference to the situation where a substance being administered to a patient is subjected substantially to one pole of a bipolar magnet during administration and/or prior to and/or after administration of the substance.
Various embodiments of the invention include S. 20 administering therapeutic amounts of the magnetic mixture in oral, injeoiable, topical and auricular forms.
Further, depending upon the condition being treated the dosage and frequency of administration will vary. In a particularly preferred embodiment the patient is 25 administered with a regimen of both oral and injectable dosages.
0 BRIEF DESCRIPTION OF THE DRAWINGS Non-limiting aspects of the present invertion are illustrated by the accompanying drawings in whichi e 8121535A S I in WO 89/09049 PCT/US89/01400 -8-i Figures 1A and IB show two preferred embodiments of oral delivery vehicles for the administration of homeopathic medicaments; Figures 2A and 2B show embodiments for the topical administration of a homeopathic medicament; Figure 3 shows a preferred embodiment for imparting a magnetic field to the injectable form homeopathic medicaments; and DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS OF THE INVENTION The homeopathic medicaments of the present invention when administered through specific acupuncture sites have demonstrated remarkable efficacy in the treatment of a wide range of afflictions, many of which have no known cure in the realm of allopathic medicine. Effective delivery systems for these homeopathic formulations have been devised including topical, injectable, auricular and oral forms.
In accordance with the teaching of the present invention the homeopathic medicament, administered in whatever form is selected, must first be carefully mixed with an effective amount of a magnetically permeable ingredient.
Although numerous compounds are suitable, it has been found that fer,'ous gluconate is particularly effective. The resulting mixture is then prepared for administration to the patient depending upon the specific delivery system used.
During administration to the patient, the medicament is charged or influenced by a magnetic field which imparts a unipolar charge to the medicament as it enters the body through a pre-selected acupuncture point. Such application of a magnetic charge at or in close proximity to the acupuncture site is believed to stimulate or activate the acupuncture site thereby enhancing the therapeutic efficacy of the medicament being administered.
Particularly effective results have been achieved when applying relatively small levels of magnetic charge in the range of 1 to 10 gauss to the medicament as it is being administered through the acupuncture point, Such low levels I WO 89/09049 PCT/US89/01400 -9z f magnetic flux can aptly be described acs homeopathic. It has further been found that the most 9P"ctive acupuncture sites are located in the arms and legs below the elbow and knee, respectively. These points are commoniy referred to s the "command points" and are well known to those skilled ir the art.
Having described the invention in its most fundamental terms, the various forms of administ:ation of medicament will now be described in detail. Reference is made to the accompanying figures where appropriate.
One delivery system used is by injection. The formulation dosage and duration of treatment for the injectible medicaments is described in detail in the formulation examples which follow. Since it has been observed that injecting homeopathic medicaments demonstrate unexpected and significantly enhanced efficacy when a unipolar magnetic charge is imparted to the medicament during administration or injection into an acupuncture point, a device has been developed to enable the administering physician to suitably charge the medicament. One such device is shown in Figure 3.
This device consists of a housing 10 containing an electromagnetic coil 12 positioned to impart a controlled magnetic charge to plate 14. A syringe or hypodermic needle 16 used to inject the homeopathic medicament can be pdiitioned in housing 10 such that the point of the needle orf ,yinge is in close proximity to plate 14 as shown in Figure 3.
Another alternative delivery system used is the topical. One particularly preferred topical is illustrated in Figure 2A. The topical patch 20 is made of a porous material such as sintered metal capable of absorbing a therapeutic amount of homeopathic medicament. The patch 20 has an extended opening therethrough in which is tightly fitted a metal rod or core 22 which \in readily accept and retain a magnetic charge. Suitable materials include iron and nickel.
The patch 20 can then be impregnated with a therapeutic amount of desired homeopathic medicament. A unipolar magnetic charge 17 WO 89/09049 PCT/US89/01400 is then imparted to the metallic core 22 of patch 20 which is then affixed to a suitable acupuncture point.
One method for affixing the topical patch to the acupuncture point is to hold it in place with adhesive bandage, surgical tape or the like. For preparations that are to be affixed to acupuncture points on the limbs, such as on the wrists, artis, ankles or legs, the magnetically influenced houmeopathic medicament can be placed in a band which can be comfortably strapped around the member at the desired location.
In certain alternative embodiments, the homeopathic pharmaceutical formulation can be magnetized in situ by placing a permanent magnet or other source of magnetic flux on top of the portion of the homeopathic mixture to be magnetically activated.
Still another form of a topical for administering homeopathic medicaments is a pellet or "button" as illustrated in Figure 2B. Th button 30 can be stamped out under pressure in a process generally known as the sintered metal process.
To fabricate the button, a 50/50 powdered mixture of Ni (nickel) and Fe (iron) is fed into a press mold. This composition inhibits corrosion and readily accepts and holds a magnetic charge. Since the finished pellet or b4tton is porous it can easily be impregnated like a sponge with a therapeutic homeopathic tincture. The button is then formed with pressure to the desired shape.
A protrusion 32 on the underside of buttoln effectively incrcases the overall therapeutic effect of the topical by providing direct physical stimulation of the acupuncture point. Although other shapes can certainly be used, the smooth domed top of button 30 is desirable as being less Obtrusive on the surface of the skin. After the button is formed and impregnated with medicament, it is magnetically charge so that the desired polarity is imparted to the' under surface of the button which is affixed in place over a pre-selected acupuncture poiit. One polarity is on the upper surface of the button ;the domed surface away from the L -i WO 89/09049 PCT/US89/01400 skin) and the other pole is on the lower surface of the button in contact with the skin. Still another form of administering homeopathic medicaments is orally by means of a pill or tablet. Two such orrl tablets are shown in 1,igures 1A and lB.
With reference to Figure 1A, this oral device can aptly be described as a medicinal "lollipop" consisting of a rod portion 40 and a ball or bulbous portion 42. The rod is made up of a metal such as irtn capable of holding a magnetic charge. The ball portion 42 has an inert core such as molded plastic, for example. ,he rod 40 is coated with a plastic or vinyl coating 44 extending to the ball portion 42.
The ball portion 42 is coated with a homeopathic composition made of sugar and Ferrous gluconate mixed to a dilution in the range of 3x to 4x. It is then impregnated with an alcohol tincture containing the desired homeopathic medicament.
The entire device can be encased in a sanitary wrapping. To use the "lollipop" the entire device ,n its wrapping if desired is first placed in a suitable electromagnetic field. In this way, all of the metallic elements of the device are magnetized with the ball portion being charged with one polarity and the rod portion with the opposite polarity. In this manner, the therapeutic portion of the device having a unipolar charge can then be placed under the tongue of the patient in order to contact the acupuncture points in the mouth.
Alternativly, a pill as shown in Figure 1B can be used. The pill 50 has a core 52 formed of a standard homeopathic sugar globule made in conventional mannere Dry Ferrous gluconate powder (USP grade) is triturated with very fine sugar in a 1-9 proportion in a grinding machine to make a homeopathic dilution of 2X. A second dilution (designed qp 3X) is made in the came 1-9 proportions using the 2X dilution and additional sugar. Succeeding dry dilutions are made in the same manner to a. final< dilutioh of 5X. The 5X dilution of the Ferrous glucohte and iugar is jed to build inner layer 54 which surrounds the core 52. Layer 54 is built up by WO 89/09049 PCT/US89/01400 -12tumbling in a coating pan in accordance with known methods for the Manufacture of homeopathic remedies. Layer 54 is then covered with a coating 56 which is i!permeable to water and alcohol. Ferrous gluconate is added to aeating 56 co that it will have the same magnetic permeability as layer 54 containing ferrous gluconate and sugar. An outer layer 58 is then built up around coating 56 in the same manner as inner layer 54 was formed. The thickness of outer layer 58 should he approximately twice that of inner layer 52 for optimum results anid is similarly made of a Ferrous gluconate sugar mixture in 5X dilution. The pills are then thoroughly air dried. The diameter of the finished pill should preferably be approximately one centimeter.
The layered pill made according to this procedure can then be medicated in conventional manner. For example, a measured weight of the finished, dried pills is placed in a suitable container and a predetexined amount of the desired homeopathic medicinal tincture is added. The homeopathic tincture is of a dilution of 3QX which has been manufactured in accordance with traditjfal homeopathic procedure from herbs or other raw materials. The containers with the pills are then rotated in a roller 'mill for approximately one hour to permit the pills to compl\tely absorb the alcohol tincture.
The pills are then transferred from the containers to paper covered trays where they ire air dried until no trace or odor of the alcohol remains. 'e t ills are then individually packaged (a single pill to each container) in a vial-like tube with a threaded cap or tiqhtly fitting friction lid. The cap is preferably larger in diameter than the vial so that it projects to form a rim around the vial at the top. Precantiorts should be taken during processing to avoid contamination oi' de-activation of the pills.
The medicated pills can" then be administered to the patient. A vial containing the pills is placed into suitable magnetic filed so that each pill is magnetized just pricr to ingestion by the patient, The pill should be inserted directly into the mouth from the vial without handling. The 1 WO 89/0o9 PC/US89/01400 -13patient can then suck on the pill to gradually dissolve it until the impermeable coating is reached at which point the patient should discard the remainder of the pill.
SYet another form of administering the homeopathic medicaments is by auricular measures. One such device consists of an earplug containing dosages of the homeopathic medicamelnt which can be administered through holes in the earplug to the acupuncture points in the ear. The earplug device can be made by any number of means with the understanding that if must be able to uncontrollably release medicament to predetermined auricular acupuncture points. This can best be accomplished by either using rods or small protrusions aligned with the acupuncture points and capable of releasing medicament. For best results, the homeopathic medicament is magnetized after it is deposited in the earplug device in accordance with the procedure described above for imparting a magnetic charge to the topical or oral forms of administration.
The following examples illustrate the embodiments of various aspects of the invention. The examples are provided to illustrate the scope of the invention and are not intended to be limiting. Other applications of aspects of the invention within its broad scope will be apparent to those skilled in the art.
FORMULATION EXAMPLES A. INJECTABLE Example 1 An injectable dosage form of an herb-based homeopathic medicament designated FNG-11, for the treatment of fungus and yeast infections, having a homeopathic potency of 30X was prepared from an original concentrated tinctcre menstrum containing extracts of the herbs Tecoma conspicua and Melaleuca alternifolia in 99+% alcohol. The original concentrated tincture then diluted to 30X potency (10 30 times thq original concentration) with sterile isotonicq saline. Ferrous gluconate, a imagnetically perme ble substance -4 in a homeopathic potency of 4 x (10 was added to the II 'N WO 89/09049 PCT/US89/01400 -14dilute homeopathic solution in order for it to hold a magnetic charge whcn passed through a magnetic field. Injectable dosage portions of 0.2cc volume- were set aside as needed depending upon the number of acupuncture points being used.
formulations injected were controllably magnetized during administration through the acupuncture sites as described above.
Example 2 An injectable dosage form of an herb-based homeopathic medicament, designated HG-9, for the treatment of intestinal parasites, particularly Giardia lamblia and Entamoeba histolytica, was prepared from an original concentrated tincture menstruum containing extracts of the herbs Osbeckia chinensis, Pulsatilla chinensis, Punica granatum, Acalpha australis, Cephaelis ipecacuanha, Picrasma ailanthoides, Asarum sieboldi, Brucea javanica, Magnolia officinalis, Artemysia apiacea, and Dichroa febrifuga in 99+% alcohol. The original concentrated tincture was then diluted -30 to 30X potency (10 3 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic potency of 4 X (10-4), was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above.
Example 3 An injectable dosage form of an herb-based homeopathic medicament designated VR-27, for the treatment of broad spectrum viral infections, having a homeopathic potency of 30X was prepared from an original concentrated tincture menstruum containing an extract of the herb Centella asiatica minor in 99+% alcohol. The original concentrated tincture was then diluted to 30X potency (10 3 times the original concentration) with sterile isotonic sali e. Ferrous gluconate, a magnetically permeable substa ce in a homeopathic WO 89/094 PCT/US89/01400 potency !bf 4 x was added to the dilute homeopathic, 19o lu tib n in order for i t to hold a magnetic charge when passed through a m~agnetic f ield. injectable dosage portions of 0.2cc volumes w P: f s et-1 aside as needed. The formulations ected 5 were controllably, magnetized dturing administration through the *acupuncture sites as described above.
Example 4 An injectable dosage form of an herb-based homeopathic medicamient. designated SPN-7, for the treatment, of traumatic injury to muscles, tendons, ligaments, and for the treatment of sprains, was prepared from an original concentrated tincture menstruum containing extracts of the herbs Radix pseudoginseng, Dryobalanops aromatica, Gynura segetum, and Moszchus xnoschif'arous in 99+% alcohol. '."he original concentrated tincture was then diluted to 30X potency 30 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic potency of 4 x (10- was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed, The formulations injected were controllably magnetized during administration through the acupunctu.Ze sites as described above.
Eampe 5An injectable do~~age forrt of an herb-based homeopathic mediqataent, designated TYR-lO, for the treatment I of hypothyroid.ism, wan prepared froi' an original, concentrated ti'nctu~e menstruum containiv' an extract of the herb Organ 30 protEomorphocim in 199+% alcohel. The original! concentrated tincture was then eiluted to 30X-potency (10 -30 times, the original concentration) with sterile isotonic saline Verroup, g4'ucoznate, a magnetically per~ea\,1_e subctance in i homeopathic -4K potency of 4 x was addod to the dilute hofviopathic Solution in order for, it to -hold a magmatic charge when passed throuch a magnetic field. Injectable dosage porti ns of 0.2cc llumes were' set aside as neede'a., The formulation injccted
A,
Mm WO 89/09049 PCT/US89/01400 -16were controliably magnetized during administration through the acupuncture sites as described above.
Example 6 i:l An injectable dosage form of an herb-based homeopathic medicament, designated HRM-4, for the treatment of premenstrual syndrome, menopause, and reproductive hormonal imbalance, was pr-parea from an original concentrated tincture menstruum containing an extract of the herb Angelica sinensis in 99+% alcohol. The original concentrated tincture was then -30 diluted to 30X potency (10 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic -4 potency of 4 x 10-4), was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above.
Example 7 An injectable dosage form of a homeopathic medicament, designated HYT-12, for the treatment of hydrothyroidism, was prepared from an original concentrated tincture menstruum containing a solution of aqueous iodine i.
alcohol. The original concentrated tincture was dilutd -30 to 30X potency (10 times the original concentration) vith sterile isotonic saline. Ferrous gluconate, a magnetically
-A?
permeable substance in a homeopathic potency of 4 x was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above.
Example 8 An injectable dosage form of an herb-based homeopathic medicament for the treatment of hypertension, designated RLX-22, was prepared "rom an origiial, tincture XJ 3'i
I'
il 3,3 WO 89/0909 PCTUS89/01400 -17menstruunt containing'extracts of the herbs Rock Foce, Clematis, Impatiens, Cherry Plum, and Star of Bethlehem in 99+% alcohol. The oricinal concentrated tincture was then diluted to 30X potency (10, 5 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic potency of 4 x (10) was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above.
Example 9 An injectable dosage form of an herb-based homeopathic medicament, designated IMM-2, for restoring and strengthening the body's natural immune system, having a homeopathic potency of 30X was prepared from an original concentrated tincture menstruum containing extracts of the herbs Astragalus membranaceous, Nux vomica, Panix ginseng, Germanium and extract of Thymus gland in 99+% alcohol. The original concentrated tincture was then diluted to 30X potency -30 0 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance -4 in a homeopathic potency of 4 x (10 was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed.
The formulations injected were controllably magnetized during -administration through the acupuncture sites as described above.
Example An injectable dosage form of a homeopathic medicament for the treatment of hypoglycemia, designated i HYG-6, was prqpared from an original concentrated tincture menstruum contlining sulfur and glycerin in 99+% alcohol. The original concentrated tincture was then diluted to 30X potency times the original concentration) wi,,h sterile isotonic j p *I I- 1 1 WO 89/09049 PCT/US89/01400 -18saline. Ferrous gluconate, a magnetically permeable substance -4 in a homeopathic potency of 4 x (10 was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed.
The formulations injected were controllably magnetized during administration through the acupuncture sites as described above.
Example 11 An injectable dosage form of an herb-based homeopathic medicament, designated INF-16, for the treatment of bacterial infections, particularly staff and strep, was prepared from an original concentrated tincture menstruum containing extracts of the herbs Senecia scandens, Scutellaria baicalensis, Magnolia officinalis, Lonicera japonica, and Andrographis paniculata in 99r% alcohol. 'he original concentrated tincture was then diluted to 3tX potency (1030 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic potency of 4 x (10- was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2co volumes were set aside as needed.
The formulations injected were controllably magnetized during administration through the acupuncture sites as described above.
Example 12 An injectable dosage form of an herb-based homeopathic iaedicament, designated FLU-17, for the treatment of viral infections due to colds and influenza, particularly rhino-virus, was prepared from an original concentrated tincture menstruum containing extracts of the herbs Lonicera confusa, Chrysanthemum indicum, Vitex negundo, Eucdia Jepta, Ilex asprella, Menthol, and Baphicacanthus cusia in 99+% alcohol. The original concentrated tincture was then diluted to 30X potency (1030 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically WO 89/09049 PCT/US89/01400 G I WO 89/09049 PCT/US89/01400 -19- -4 permeable substance in a homeopathic potency of 4 x (10 was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The fcrmulations injitted were controllably magnetized during administration through the acupuncture sites as described above.
Example 13 An injectable dosage form of an herb-based homeopathic medicament, designated ALL-5, for the treatment of hayfever and airborne allergies, was prepared from an original concentrated tincture menstruum containing extracts of the herbs Gentiana luta, Citrus aurantium, Tanacetum vulgare, Chicus bentdictus, Menyanthes trifoliata, Grindelia robusta, and Ephedra sinica in 99+% alcohol. The original concentrated tincture was then diluted to 30X potency (10 30 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic -4 potency of 4 x (10 was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic tield, Injectable dosage portions of 0.2cc vclumes were set aside as needed. The formulations injected were controllably magnetized at the time of administration through the acupuncture sites as described above.
Example 14 An injectable dosage form of an herb-based homeopathic medicament, designated OPN-26, for the treatment of chronic muscular and joint pain, was prepared from an original concentrated tincture menstruum containing an extract of the herb Rhus toxicodndron in 99+% alcohol. The original concentrated tincture was then diluted to 30X potency (10 30 times the original concentration) with sterile isotonic saline. Ferrous gluconate. 'h magnetically permeable substance in a homeopathic potency of 4 (10 was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc-voumes were set aside as needed.
WO 89/09049 PCT/US89/01400 The formulations injected were controllably magnetized during administration through the acupuncture sites as described above.
Example An injectable dosag'e form of a homeopathic medicament, designated SMK-30, for the treatment of nicotine addiction and the craving to smoke cigarettes, other nicotine containing tobacco products, and the like, having a homeopathic potency of 30X was prepared from an original concentrated tincture menstruum containing an extract of cigarette smoke in 99+% alcohol. The original concentrated tincture was then diluted to 30X potency (10 30 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic potency of 4 x was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above.
B. ORAL FORM Example 16 An oral dosage form of the herb-based homeopathic medicament FNG-11, prepared as set forth in Example 1 above, having a homeopathic potency of 30X was prepared in accordance with the procedure described above in connection with the pill illustrated in Figure lB.
Example 17 An oral dosage form of the herb-based homeopathic medicament HG-9, as in Example 2, having a homeopathic potency of 30X, was prepared according to the method of Example 16.
Example 18 An oral dosage form of the herb-based homeopathic medicament VR-27, as in Example 3, having a homeopathic potency of 30X, was prepared according to the method of Example 16.
s I.
WO 89/09049 PCT/US89/0 1400 Example 19 An oral dosage form of the herb-based homeopathic medicament SPN-71 as in Example 4, having a homeopathic potency of 30X, wias prepared according to the method of Example lb.
Example An oral dosage form of the homeopathic miedicament rY 10 as in Example 5, having a homeopathic potency of was prepared according to the method of Example 16.
Example 21 An oral dosage form of the herb-based homeopathic mreticament HRI4-4, as in Example 6, having a homeopathic potency of 30X, was prepared according to the method of Example 16.
Example 22 An oral dosage form of the homieopathic medicamient TYR-12, as in Example 7, having a homeopathic potency of was prepared according to the method of Example 16.
Example 23 An oral dosage form of the herb;-based homeopathic medicament RLX-22, as in Example 8, having a homeopathic potency of 30X, was prepared according to the method of Example 16.
Exarayle 24 An oral dosage form of the herb-based homeopathic medicament IMM-2, as in Example 9, having a homeopatic potency of 30X, was prepared according to the method of Example 16.
An oral dozagti rorm of the herb-based homeopathic medicament HYG-6, as in Example 10, having a homeopathic potency cf ?OX, was prepared according to the method of, Example 16.
Examplo 26 An oral dosage form of4 the herb-based homneopathic medicament Iur-16, as in Example 11, havingc a horeopathic potency of 30Xf was prepared according to the method oz' ExampleL 16.
WO 89/09049 PCT/US89/01400 WO 89/09049 PCT/US89/01400 -22- Example 27 An oral dosage forn of the herb-based homeopathic medicament GLG-17, as in Example 12, having a homeopathic potency of 30X, was prepared according to the method of Example 16.
Example 28 An oral dosage form of the herb-based homeopathic medicament ALL-5, as in Example 13. having a homeopathic potency of 30X, was prepared according to the method of Example 16.
Example 29 An oral dosage form of the herb-based homeopathic medicament OPN-26, as in Example 14, having a homeopathic potency of 30X, was prepared according to the method of Example 16.
Example An oral dosage form of an herb-based homeopathic medicament, designated GU-14, for the treatment of gastric discomfort, horborygmi, and flatus, having a homeopathic potency of 30X, was prepared according to the method of Example 16, where the original concentrated tincture menstruum contained extracts of the herb Coryaidrus sativa.
Clinical Examples Example 31 A combined treatment reginen utilizing both the injectable and oral dosage forms of the FNG-11 homeopathic medicament (prepared according to Examples 1 and 16, respectively), was used in the treatment of a 44 year old female patient. Prior to treatment the patient exhibited symptoms including mood swings, premenstrual syndrome and fatigue, and was diagnosed as a result of visible yeast in a live cell analysis as suffering from candidiasis. The injectable form dosage of FNG-11 was administered two times per week during the first week and once per week thereafter bilaterally to the two SP-6 acupuncture points. Duration of treatment by the injectable mode was for a total period of four weeks. Oral dosage forms were WO 89/09049 SwPCTUS89/01400 -34- WO 89/09049 PCT/US89/01400 -23administered at an initial dosage rate of 3 tablets taken times per day during the first week of treatment, reduced to 3 times per day during the second week of treatment and finally to 2 times per day for the balance of the duration of the treatment. The total duration of treatment under the oral form was for a period of 4 weeks. As a result of the above treatments, the patient's blood level yeast decreased by The patient's P.M.S. and other symptoms were controlled.
Example 32 A combined treatment regimen utilizing both the injectable and oral dosage forms of the VR-27 homOpathic medicament (prepared according to Examples 3 and 18, respectively), was used in the treatment ot a 41 year old male exhibiting symptoms including a history of prostatitis and gonorrhea with active leisons approximately 60-70% of the time. The patient was diagnosed as being infected with herpes simplex 2. The injectable form dosage of the VR-27 was administered two times per week during the first week and once per week thereafter bilaterally to the two TW-5 acupuncture points and the oral form dosage was administered initialJy at a rate of 3 tablets taken 5 times per day during the first week of treatment, reduced to 3 times per day during the second week of treatment and finally to 2 times per day for the balance of the duration of the treatment. Both the injectable and oral form dosages were admin'itered for a total treatment period of 6 weeks. After 3 weeks of treatment, the patient's condition improved to the extent that there were no active lesions and no further outbreaks of genital herpes.
Example 33 A combined treatment regimen of oral and injectable 1j forms of VR-27 was utilized in the treatment of a 33 year old female of slender build and good muscle structure. The patient exhibited classic symptoms of Chronic Epstein-Barr Virus including chronic fatigue, unrefreshed sleep, dark circles under the eyes, headaches, burning eyes, hypersensitivity to bright lights and smoke, non-specific musloa aches in shifting locales, lack of coordination, lack R
^A
9,-09049 PCT/US89/01400 -24ofbalance, n pesistent bouts of depres/sions t4hat somaetimes reached profouind levels. She was uncertaLl o >xct dates but =elt that she had had most oi these syrnpt~ms for several yea-rs.
A bloo:G test verified the diagnosis of Epstein-Barr virus. The E-D Virus antibody virus titer (VCA)) was positive at 1:5120.
The patient was treated on a weekly basis with the homeopathic medicament by taking 3 oral tables t.i.d. The injectable form of VR-27 was injected through the TWq-5 acupuncoture point. Treatment continued for a period of approximately 2 months. At the end of this time the iollow-up blood work showed that the same anti-body titer had fallen to a Jevel of 1:320; Well below the critical point and within the range considered normal. The clinical signs and symptomos onfirmed the lab work and the patient reported virtual.
freedom fromr he previous physical and emotional problems.
She continued to be free of symptoms 1S months later.
Example 34 A female patient 36 years old, who was slightly overweight exhibited symptoms of constant vaginal infections with associated burning, itching and diS.charge. She cornplained of extremely low energy level and felt that she wras in a state of unremitting depression,, Frequent attacks of acute diarrhea after food intak~e weve accomrpanied by headaches and nasa he feels much of lbh~a weight problm is water re- 1t,,ntion (abdominal bloating) and reports a large number of various food allergies. Relativelv' the same roster of complaints have beon present in various combination for a period that, 4he estimates, could be as long as twelve years. The patient diagnosed as suffering froni chronic candida albicans.
Init-al la~boratory tests disclosed the .4ollowing levels:.
IgG 136 (normial max 100) IcrA 21 (normal max 100) 1gM lo l (normal max 100) ,The patient was treated with FNG-11. in inj( ctablc fonk, int,,odvuced into acupuncture point SP-6 on a once a week basis in WO 89/09049 PCT/US89/01400, addition to oral tablets of the same medI-i tion for 8 weeks.
Followi;ng treatment laboratory tests d Iiscl se~l the following
Y
levels: 1 IgG 51 ICJA 96 1gM 99 The patient also reported a total cessation of the ipitiatiny and chronic symptoms complai-ned of and has been fully comfortable i-,ith no recurrence since.

Claims (35)

1. A method for treating pathogenic conditions of the human body comprising the steps of: preparing a therapeutically effective amount of a mixture of at least one herb, herbal extract or other compound having therapeutic p,operties to which a particular condition being ",reated is responsive; adding a magnetically permeable active substance to the mixture; magnetizing the resulting mixture in a magnetic field to impart a substantially unipolar magnetic charge on said mixture; and administering the magnetized mixture through one or more specific acupuncture points of the body which are associated with producing a desired response to the particular condition being treated.
2. The method of claim 1 wherein the mixture is 20 magnetized in a magnetic field of less than ten gauss.
3. The method of claim 1 wherein the magnetized mixture is topically administered to the body.
4. The method of claim 1 wherein the magnetized mixture 25 is injectably administered to the body.
5. The method of claim 1 wherein the magnetized mixture is auricularly administered to the body,
6. The method of claim 1 wherein the magnetized mixture is orally administered to the body.
7. The method of claim 3 wherein a therapeutic amount of the magnetized mixture is placed over at least one of said acupuncture points on the surface of the body.
8. The method of claim 4 wherein a therapeutic amount 3- of the magnetized mixture is injected into at least one of said acupuncture points of the body.
9. The method of claim 5 wherein a therapeutic amount of the magnetized mixture is placed in receptacles 32A wk^ 2*3 v i J 1, 1 r c -26A- in a device for insertion into the auricular meatus, the receptacles being located in said device such that the magnetized mixture is in contact with at least one auricular acupuncture point when the device is inserted in the auricular meatus. r r I I i i: 1i j, i ~I S:21535A it I WO 89/0904 PCT/US89/01400 -27- The method of claim 6 wherein a therapeutic amount of the magnetized mixture, formed into a pill having an inert sugar-based core surrounded by a first layer comprised of a mixture of sugar and magnetically permeable compound and said first layer is coated with a magnetically permeable layer which is impermeable to water and alcohol and said coating is surrounded by a second layer substantially the same compositions as the first layer and approximately twice the diameter, is placed in the mouth upon being controllably magnetized and the patient sucks on the pill until the second layer is dissolved and the impermeable coating is reached after which the pill is discarded.
11. The method of claim 6 wherein a therapeutic amount of the magnetized mixture is administered to acupuncture points in the mouth by means of an oral delivery device which is magnetically transparent and permeable comprising a rod portion connected to a ball wherein said rod portion having a core capable of accepting and holding a magnetic charge and covered by a plastic or vinyl coating extending to the ball portion which is impregnated with an effective amount of said mixture, wherein said ball portion of the device is magnetized to one polarity and the patient then places the ball portion of the device under the tongue to activate the acupuncture points.
12. The method of claim 7 wherein the mixture of at least one therapeutic herb and a magnetically permeable substace is magnetized by placing a source of magnetic flux in proximity to the mixture while it is placed over one or more acupuncture points on the surface of the body.
13. A method for the treatment of conditions of the human body including injuries, illnesses, pathogenic diseases, allergies and chemical and hormonal imbalances, the method comprising the administration of a combination of oral and injectable forms of a therapeutic amount of a magnetized solution containing a solute of one or more therapeutic herbs or herbal extracts or other compounds having properties to which the particular cndition being treated is responsive, the solute being dissolved in a solvent, where the solvent for the oral form is a mixture of 99+% alcohol, and the solvent Sk i 6 k] WO 89/09049 PCT/US89/01400 -28- for tle injectable form is a: mixture of 99+% alcohol diluted with sterile isotonic salinej together with a magnetically permeable, non-toxic substance; and wherein the oral form is impregnated into a solid placed in the mouth to release the magnetized mixture contained therein thereby stimulating acupuncture points in the mouth; and where the injectable form is injected at specific acupuncture points of the body related to the part of the body or the condition being treated; the oral and injectable treatments being administered in appropriate dosages for a sufficient period of time depending on the severity of the condition and the response of the patient being treated, with provision for a further period of maintenance treatments of different dosage and frequency of administration where symptoms of the condition persist.
14. The method of claim 11 wherein the condition being treated is traumatic injury to one or more joints, muscles, tendons and ligaments and the solute ot the magnetized solution comprises an effective amount of one or more herbs or herbal extracts selected from the group consisting of Radix pseudoginseng, Dryobalanops aromatica, Gynura segetum and Moschus moschiferous. The method of claim 14 wherein the oral dosage is a tablet having a homeopathic potency of 30X, administered initially as 2 tablets three times per day, reduced to two times per day and finally to once per day over the course of treatment; wherein the injectable dosa.ge is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 30X, administered to the acupuncture points and related local acupuncture points for the specific injured member being treated, the injections being given initially 2 times per week for the first week of treatment and once per week on successive weeks over the course of treatment; and wherein the duration of both the oral and injectable modes of treatment is from 1 to 6 weeks, followed by a period of maintenance of several weeks where symptoms of the condition persist.
16. The method of claim 11 wherein the condition being treated is hypothyroidism and the solute of the "l INTERNATIONAL SEARCH REPORT Intrcnatonal Apc tion No, PC~'PrI i 4nn WO 89/09049 PCT/US8901400 K -29- magnetized solution comprises an extract of thyroid organ protomorphogin.
17. The method of claim ]4 wherein the oral dosage is a tablet having a hioeopathic potency of 3OX, administered initially as 2 tablets three times per day, reduced to two times per day and finally to once per day over the course of treatment; wherein the injectable dosage is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 30X, administered bilaterally to each of the two LI-11 acupuncture points, the injections being given initially 2 times per week for the first week of treatment and once per week on successive weeks over the course of treatment; and wherein the duration of both the oral and injectable modes of treatment is six weeks, followed by a period of maintenance of several weeks where symptoms of the condition persist.
18. The method of claim 11 wherein the condition being treated is one or more of pre-menstrual syndrome, menopause and reproductive hormonal imbalance in female human beings and the solute of the magnetized solution comprises the herb Angelica sinensis or an extract thereof.
19. The method of claim G1 wherein the oral dosage is a table- having a homeopathic potency of 30X, administered initially as 2 tablets three times per day, reduced to two times per day and finally to once per day over the course of treatment; wherein the injectable dosage is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 30X, administered bilaterally to each of the two SP-6 acupuncture points, the injections being given initially from 1 to 2 times per week for the first week of treatment and once per week on successiv weeks over the course of treatment; and wherein the duration of both the oral and injectable modes of treatment is from 1 to 2 weeks, followed by a period of maintenance of several weeks where the symptoms of the condition persist. The method of claim 11 wherein the condition being /reated is emotionsaldepressions, and hypertension and the solut' of the magnetized solution comprises one or more herb cr/herbal extracts selected from the group consisting of i b a WO 89/09049 PCT/US89/01400 Rock Rose, Clematis, Impatiens, Cherry Plum, and Star of Bethlehem.
21. The method of claim 18 wherein the oral dosage is a tablet having a homeopathic potency of 30X, administered initially as 2 tablets three times per day, reduced to two times per day and finally to once per day over the course of treatment; wherein the injectable dosage is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 30X, administered bilaterally to one pair of the HE-5, HE-6 or HE-7 acupuncture points, administered a total of once or twice; and wherein the duration of the oral mode of treatment is from 1 to 6 weeks, followed by a period of maintenance of several weeks whsre symptoms of the condition persist.
22. The method of claim 11 wherein the condition being treated is a reduction in the body's natural immune system and the solute of the magnetized solution comprises one or more herbs or herbal extracts selected from the group consisting of Anthemis nobilis, Smilax officinalis, Angelica officinalis, Medicago sativa, Rhamnus purschiana, Apiunm graveolens, Astragalus membranaceous, Taraxacum officinale, Gentiana lutea, Marrubium vulgare, Glycyrrhiza glabra, Passiflora incarnata, Serenoa serrulata, and Polygala senega.
23. The method of claim 20 wherein the oral dosage is a tablet having a homeopathic potency of 30X, administered initially as 2 tablets three times per day, reducea to two times per day and finally to once per day over thd course of treatment; wherein the injectable dosage is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 30X, administered bilaterally to each pair of the LI-11, SP-6, HE-5, HE-6 and HE-7 acupuncture points, the injection being given initially 2 times per week for the first week of treatment and once per week on successive weeks over the course of treatment; and wherein the durstion of both the oral and injectable modes of treatment is 6 weeks, followed by a per od of maintenance of seve 'al weeks where symptoms of the condition persist. K( WO 89/09049 PCT/US89/01400 2 -31-
24. The method of claim 11 wherein the condition Pbeing treated is hypoglycemia and the solute of the magnetized solution comprises a mixture of sulfur and glycerin. The method of claim 22 wherein the oral dosage is a tablet having a homeopathic potency of 30X, administered initially as 2 tablets three times per day, reduced to two times per day and finally to once per day over the course of treatment; wherein the injectable dosage is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 30X, administered bilaterally to each of the two ST-36 acupuncture points initially 2 times per week for the first week of treatment and once per week on successive weeks over the course of treatment; and wherein the duration of both the oral and injectable modes of treatment is 2 weeks, followed by a period of maintenance of several weeks where the symptoms of the condition persist.
26. The method of claim 11 wherein the condition being treated is a general or localized bacterial infection of the body, and the solute of the magnetized solution comprises one or more herbs or herbal extracts selected from the group consisting of Senecia scandens, Scutellaria baicalensis, Magnolia officinalis, Lonicera japonica, and Andrographis paniculata.
27. The method ot claim 24 wherein the oral dosage is a tablet having a homeopathic potency of 30X, administered initially as 2 tablets three times per day, reduced to two times per day and finally to once per day over the course of treatment; wherein the injectable dosage is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 30X, administered bilaterally to each of the two LI-11 acput tute points, the injections being given initially 2 times per week ,or the tirst week of treatment and once per week on successive eeks over the course of treatment; and wherein the dt~rat Co of both the oral and injectable modes of treatment is from 2 to 6 weeks, followed by a period of maintenance ot several weeks where symptoms of the condition persist.
28. The method of claim 11 wherein the condition being treated is a general viruc Infection of the body and the 1 n L WO 89/09049 PC '9/01400 solute of the magnetized solution comprises the herb Cente!lla asiatica minor or an extract thereof.
29. The method of claim 26 wherein the oral dosage is a tablet having a homeopathic potency of 30X, administered initially as 2 tablets three times per day, reduced to two times per day and finally to once per day over the course of treatment; wherein the injectable dosage is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of from 5X to 30X, administered bilaterally to each of the two TW-5 acupuncture points, the injections being given initially 2 times per week for the first week of treatment and once per week on successive weeks over the course of treatment; and wherein the duration ot both the oral and injectable modes of treatment is 6 weeks, followed by 4 period of maintenance of several weeks where the symptoms of the condition persist. The method of claim 11 wherein the condition being treated is a cold caused by the rhino-virus or influenza and the solute of the magnetized solution comprises one or more herbs or herbal extracts selected from the group consisting of Lonicera confusa, Chrysanthemum indicum, Vitex negundo, Eucdia lepta, Ilex asprella, Menthol, and Baphicacanthus cusia.
31. The method of claim 28 wherein the oral dosage is a tablet having a homeopathic potency of 30X, administered initially as 2 tablets three times per day, reduced to two times per day and finally to once per day over the course of treatment; wherein the injectable dosage is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 5X. administered bilaterally to each of the two TW-5 acupuncture points, the injections being given initially 1 or 2 times per week for the first week of treatment and once per week on successive weeks over the course of treatment; and wherein the duration of both the oral and injectable modes of treatment is from 1 to 3 weeks, followed by a period of maintenance of several weeks where symptoms of the condition persist.
32. The method of claim 11 wherein the condition being treated isone or more of hay fever and airborne i WO 89/09049 PCT/US89/01400 -33- allergies caused by pollens, spores and the like, ah the solute of the magnetized solution comprises one or more herbs or herbal extracts selected from the group consisting of Gentiana luta, Citrus aurantium, Tanacetum vulgare, Chicus benedictus, Menyanthes trifoliata, Grindelia robusta, and Ephedra sinica.
33. The method of claim 30 wherein the oral dosage is a tablet having a homeopathic potency of 5X administered initially as 2 tablets three times per day, reduced to two times per day and finally to once per day over the course of treatment; wherein the injectable dosage is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 30X, administered bilaterally to each of the two SP-9 acupuncture points, the injections being given initially 2 times per week for the first week of treatment and once per week on successive weeks over the course of treatment; and wherein the duration of both the oral and injectable modes of treatment is three weeks, followed by a period of maintenance of several weeks where symptoms of the condition persist.
34. The method of claim 11 wherein the condition being treated is one or more of local and systemic fungus and yeast infections, and the solute of the magnetized solution comprises one or more herbs or herbal extracts selected from the group consisting of Tecoma conspicua and Melaleuca alternifolia. The method of claim 32 wherein the oral dosage is a tablet having a homeopathic potency of 30X, administered initially as 2 tablets three times per day, reduced to two times per day and tinally to once per day over the course of treatment; wherein the inject4ble dosage is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of from 30: to 30X, administered bilaterally to each of the two SP-6 acupuncture points, the injection being given initially 2 times per week for the firct week of treatment and once per week on successive weeks over the course of treatment; and wherein the duration of both the oral and injectable modes of treatment is from 2 to 4 weeks, WO 89/09049 PCT/US89/01400 -34- followed by a period of maintenance of several weeks where the symptoms of the condition persist.
36. The method of claim 11 wherein thE condition, being treated is infestation with intestinal pay sites and the solute of the magnetized solution comprises one 6r more herbs or herbal extracts selected from the group consisting of Osbeckia chinensis, Pulsatilla chinensis, Punica granatum, Acalpha australis, Cephaelis ipecacuanha, Picrasma ailanthoides, Asarum sieboldi, Brucea javanica, Magnolia officinalis, Artemisia apiacea, and Dichroa febrifuga.
37. The method of claim 34 wherein the oral dosage is a tablet having a homeopathic potency of 30X, administered initially as 2 tablets three times per day, reduced to two times per day and finally to once per day over the course of treatment; wherein the injectable dosage is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 30X, administered bilaterally to both pairs of the ST-36 and ST-37 acupuncture points, the injections being given initially 2 times per week for the first week of treatment and once per week on successive weeks over the course of treatment; and wherein the duration of both the oral and injectable modes of treatment is from 4 to 6 weeks, followed by a period of maintenance of several weeks where symptoms of the condition persist.
38. The method of claim 11 wherein the condition being treated is chronic muscular and joint pain and the solute of the magnetized solution comprises the herb Rhus to,:icodendron or an extract thereof.
39. The method of claim 36 wherein the oral dosage is a tablet having a homeopathic potency of 30X, administered initially as 2 tablets three times per day, reduced to two times per day and finally to once per day over the course of treatment; wherein the injectable dosage is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 30X, administered to the trigger acupuncture points relating to the members where pain is experienced and to specific pain points, the injections being given initially 2 times per week for the firtt weck of treatment and once per weok on successive weeks over the course of treatment; and wherein the duration of both the oral and injectable mades of treatment is from one to sixc Trc~ followed by a period of maintenance of emveral wJsif i equired.
40. A method for the treatment of at least one of gastric discomfort, borborygmi and flatus in human beiLngs comprising the administration of an oral form of a therapeutic amount of a magnetized solution containing as a solute the herb Coryandius sativa or an extract thereof and as a solvent a mixture of 99+% alcohol, diluted with ethanol, together with a magnetical~ly permeable, non-toxic substance; wherein the oral form is a milk-sugar tablet carrier impregnated with the oral form solution; the tablet having a homeopathic potency of 5X; wherein the tablet is allowed to dissolve in the mouth to coat the acupuncture points in the mucous membrane of the 4:L The method of claim 38, wherein 3 tablets Eire 20 administered as frequently as necessary until V466,pall~iative relief of symrptoms Is experienced. *042, A method for the treatment of nicotin~e addiction- and the craving to smoke cigarettes, other nicotine containing tobacco products, -and the like in human 25 beings, comprising the administration of an Sinjectable form of a therapeutic amount of a magnetized solution containing as a solute cigarette smoke or an extract thereof and as a solvent a mixture of 99+% alcohol diluted with sterile isotonic salire, together with a magnetically permeable, non-toxic substance; the injectable solution having a homeopathic potency of wherein the solution is injected in an am~ount of 0.2 cc per acupuncture point, bilaterally at two special acupuncture points of the body. 43o The method of claim 42 wherein the injectable magnetized solution is injected on a one-time, onlyt, basis.
44. A methud for treating pathogenic conditions of the, human body substantially as herein described with reference to any one of the Examples and/or in conjunction with Figures 1 to 3 of the accompanying drawings. Dated this 4th 0-y of Mareh 1992 WA.LTE,. WHITSON FISCHMAN By Their Patent Attorneys GRIFFITH RICK &CO. too* so 4: 2 63
AU34260/89A 1988-04-01 1989-04-03 Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration Ceased AU632481B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17673188A 1988-04-01 1988-04-01
US176731 1988-04-01

Publications (2)

Publication Number Publication Date
AU3426089A AU3426089A (en) 1989-10-16
AU632481B2 true AU632481B2 (en) 1993-01-07

Family

ID=22645606

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34260/89A Ceased AU632481B2 (en) 1988-04-01 1989-04-03 Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration

Country Status (7)

Country Link
EP (1) EP0409893A4 (en)
JP (1) JPH03503648A (en)
AU (1) AU632481B2 (en)
CA (1) CA1334936C (en)
IN (1) IN169075B (en)
NZ (1) NZ228593A (en)
WO (1) WO1989009049A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1243476B (en) * 1990-08-01 1994-06-15 Enza Ciccolo METHOD FOR THE RECOGNITION OF FREQUENTLY AND BIOENERGETIC ACTIVITIES IN WATERS AND THEIR USE
FR2675385B1 (en) * 1991-04-18 1993-07-23 Boulay Maurice CALMING AND CONDITIONING PRODUCT CONTAINING MAGNET POWDER.
WO1993003712A1 (en) * 1991-08-20 1993-03-04 Daniel Mcnair A device for the administration of homeopathic compositions
IT1290779B1 (en) * 1995-06-26 1998-12-10 Antonio Sacchetti PROCEDURE FOR THE ENHANCEMENT OF THE THERAPEUTIC ACTIVITIES OF NATURAL SUBSTANCES (VITAMINS, MINERALS, HERBS, PHYTO-PREPARATIONS, FOODS)
WO2002066041A1 (en) * 2001-02-23 2002-08-29 Herbal Detox Therapy Aps Natural composition
US6552035B2 (en) * 2001-09-13 2003-04-22 Hwa-Mok Park Composition for inducing smoking cessation comprising alkaloids from Radix ipecauanhae
US6844014B1 (en) 2002-07-22 2005-01-18 Stephen Rafkin Herbal healing lotion for veterinary use
DE202014103194U1 (en) * 2014-07-11 2014-07-29 Marianna Gross Homeopathic remedy for smoking cessation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1978000005A1 (en) * 1977-06-02 1978-12-07 K H Mosbach Magnetic polymer particles

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2671451A (en) * 1952-06-16 1954-03-09 Stephen J Bolger Remedial pill
DE1467974A1 (en) * 1964-06-08 1969-01-23 Tsukamoto Kenkichi Process for improving the effectiveness of iron preparations and device for carrying out the process
DE1492136A1 (en) * 1965-01-30 1969-09-18 Seuss Dr Med Willy Device for the therapeutic influence of the human body through static electricity
DE1692771A1 (en) * 1968-02-24 1972-01-05 Willy Dr Med Seuss Process for the preparation of internally or externally applicable physiologically active substances and agents manufactured according to them
BE759692A (en) * 1969-12-23 1971-05-17 Soliman Henri MINERAL-VEGETABLE MEDICINE
FR2258839A1 (en) * 1974-01-28 1975-08-22 Sitbon Georges Colloidal therapeutic iron solutions - treatment for cancer, leukaemia, arterial and cardiac disorders, neurological disorders, anti-radiation agents, etc.
US4357259A (en) * 1977-08-01 1982-11-02 Northwestern University Method of incorporating water-soluble heat-sensitive therapeutic agents in albumin microspheres
JPS576041A (en) * 1980-02-25 1982-01-12 Kimikiyo Harada Folding formation type metal stud
FR2477022A1 (en) * 1980-03-03 1981-09-04 Flux Yang Ste Civile DEVICE FOR THE LOCALIZED APPLICATION OF A MAGNETIC FIELD ON AN OBJECT, IN PARTICULAR A LIVING BEING
WO1983001738A1 (en) * 1981-11-12 1983-05-26 SCHRÖDER, Ulf Intravascularly administrable, magnetically responsive nanosphere or manoparticle, a process for the production thereof, and the use thereof
JPS5945378A (en) * 1982-09-09 1984-03-14 Toyobo Co Ltd Self-adhesive material
JPS6032716A (en) * 1983-07-29 1985-02-19 Yasuo Sawada Antibacterial drug containing specific fatty acid and magnetic iron oxide powder, and prepartion of drug accelerating restoration of patient
JPS61115015A (en) * 1984-11-08 1986-06-02 Shimazaki Shiyubiyou Kk Magnetized cosmetic
EP0208362A1 (en) * 1985-06-28 1987-01-14 The Procter & Gamble Company Dietary supplements containing iron and enterically coated calcium
JPS62175419A (en) * 1986-01-25 1987-08-01 Tomoji Tanaka Artificial hot spring bath agent
DE3634121A1 (en) * 1986-05-09 1987-11-12 Otto Kausch Method and device for improving the effects of liquid or pasty products
JPS63159313A (en) * 1986-12-24 1988-07-02 Olympus Optical Co Ltd Drug for treatment

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1978000005A1 (en) * 1977-06-02 1978-12-07 K H Mosbach Magnetic polymer particles

Also Published As

Publication number Publication date
WO1989009049A1 (en) 1989-10-05
EP0409893A4 (en) 1991-03-13
CA1334936C (en) 1995-03-28
NZ228593A (en) 1992-07-28
AU3426089A (en) 1989-10-16
EP0409893A1 (en) 1991-01-30
JPH03503648A (en) 1991-08-15
IN169075B (en) 1991-08-31

Similar Documents

Publication Publication Date Title
US5162037A (en) Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration
AU723812B2 (en) Medicinal preparation and a method of medicinal action on human organism
US4352796A (en) Pharmaceutically active plant extract and composition thereof
CN101417013A (en) Traditional Chinese medicine cataplasm for treating rheumatism and ostalgia and preparation method thereof
AU632481B2 (en) Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration
EP1162988A1 (en) Wafer delivery system
US5603935A (en) Composition for the treatment of snoring and methods of use thereof
CN104623376A (en) Medicament for treating prosopalgia
CN102552440B (en) Anti-asthmatic and anti-inflammatory medicament and preparation method and application thereof
CN101361868B (en) Traditional Chinese medicine combination for treating rheumatism
CN1954841B (en) Medicine for treating chronic pharyngitis
CN102614375B (en) Traditional Chinese medicine compound for tonifying kidney, strengthening yang and treating impotence and preparing method thereof
CN102727791A (en) Medicine for treating AIDS and preparation method thereof
CN102205109A (en) Chinese medicinal composition for treating rheumatism and application thereof
Biddle Materia medica
WO2002094297A1 (en) Herbal composition for the treatment of drug addiction and insomnia
CN102266408A (en) Chinese medicine preparation for intervening in cutaneous prutitus and preparation method thereof
Khalsa Low dose herbs
CN102274469A (en) Composition for preventing and treating lead poisoning and preparation method thereof
CN1126560C (en) Chinese patent medicine &#39;Wuweibaigan wine (powder)&#39; for treating gastrointestinal diseases
AU2002254806B2 (en) Herbal composition for the treatment of drug addiction and insomnia
CN1092976C (en) Application of endive in preparing medicine for treating tuberculosis
CN103599185A (en) Traditional Chinese medicine composition for treating headache
CN113491735A (en) Anti-insomnia acupoint patch
CN108969546A (en) A kind of preparation method of sundew plastics